Microsoft has upgraded its AI-powered Copilot, allowing it to generate Office documents and connect with Gmail, Outlook, and more. Discover how these features can enhance your productivity!
This afternoon at New York Comic Con, the cast and showrunners of Star Trek: Starfleet Academy revealed exciting details about the series, including character backstories, new images, and an interactive website. Join Caleb Mir on his quest to find his mother as he navigates the challenges of Starfleet Academy!
A powerful nor’easter is on track to hit New Jersey, bringing 60 mph winds and heavy rainfall, prompting state of emergency and warnings of major coastal flooding and road closures. Residents should prepare for significant impacts.
In a bold move, Russell Vought has initiated mass layoffs of federal workers as the government shutdown drags into its 11th day. With Congress at an impasse, will Democrats cave or will more workers face job loss?
Just weeks after surgery for a broken hand, Oklahoma's QB John Mateer is on track to play against Texas. His recovery journey has fans buzzing about his return in this crucial matchup!
Apple's latest iPhone 17 Pro promises better performance and a sturdier design, featuring a larger battery and impressive camera upgrades. But is it worth the upgrade? Find out here!
Bradley Cooper unveils his latest directorial venture 'Is This Thing On?' at the New York Film Festival, sharing his deep connection to the city and the comedy scene. With Arnett and Dern on board, the film promises to be a heartfelt exploration of friendship and catharsis.
MIT researchers have developed a groundbreaking method for gene editing that significantly reduces errors, making gene therapy safer and more effective for treating genetic diseases. This innovative approach promises a future of precise genomic alterations with fewer side effects.
This weekend's college football slate features exciting matchups including Ohio State at Illinois and Alabama at Missouri. Can the top teams maintain their winning streaks? Read for expert predictions and analysis!
In a bold move to reduce U.S. prescription drug prices, AstraZeneca and Pfizer have struck deals with the White House, promising significant discounts for patients. This comes amid rising pressure from President Trump on drugmakers to lower costs or face hefty tariffs. Will these changes truly benefit American patients?
